🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to test an experimental treatment met...
Status
Terminated
Location
Nicklaus Children's Hospital
Start Date
2016-02
Trial ID
NCT02684071
Treatments Being Tested
Rhegmatogenous retinal detachment (RRD) is a sight-threatening condition. C...
Status
Withdrawn
Location
Byers Eye Institute at Stanford University and Lucille Packard Children Hospital
Start Date
2021-04
Trial ID
NCT04830878
Treatments Being Tested
Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the con...
Status
Unknown
Location
University of Ghent, Department of Rheumatology
Start Date
2013-04
Trial ID
NCT01834157
The investigators are studying whether anti-inflammatory agents can improve...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2015-01
Trial ID
NCT02366091
Treatments Being Tested
Vitiligo is a common autoimmune depigmenting disorder characterized by sele...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-10
Trial ID
NCT07208890
Treatments Being Tested
Comparison of cumulative incidence of CNS relapses in patients with diffuse...
Status
Unknown
Location
University Hospital Brno-Bohunice
Start Date
2015-07
Trial ID
NCT02777736
Treatments Being Tested
Cutaneous lupus erythematosus (CLE) is a heterogeneous inflammatory autoimm...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT06965244
Treatments Being Tested
This prospective trial will assess the activity and feasibility of a new hi...
Status
Completed
Location
San Raffaele Scientific Institute
Start Date
2007-01
Trial ID
NCT00801216
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of ixekizumab co...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2016-01-20
Trial ID
NCT02634801
Treatments Being Tested
Methotrexate (MTX) is considered the 'gold-standard' drug for the treatment...
Status
Unknown
Location
Narayana Med College and Hospital
Start Date
2013-11
Trial ID
NCT02248792
Treatments Being Tested